全文获取类型
收费全文 | 212892篇 |
免费 | 51626篇 |
国内免费 | 3262篇 |
专业分类
耳鼻咽喉 | 2510篇 |
儿科学 | 6230篇 |
妇产科学 | 1444篇 |
基础医学 | 36170篇 |
口腔科学 | 9997篇 |
临床医学 | 24554篇 |
内科学 | 35771篇 |
皮肤病学 | 5612篇 |
神经病学 | 24119篇 |
特种医学 | 9073篇 |
外国民族医学 | 12篇 |
外科学 | 21559篇 |
综合类 | 15876篇 |
现状与发展 | 8篇 |
一般理论 | 11篇 |
预防医学 | 24213篇 |
眼科学 | 2650篇 |
药学 | 23441篇 |
117篇 | |
中国医学 | 7843篇 |
肿瘤学 | 16570篇 |
出版年
2024年 | 370篇 |
2023年 | 1928篇 |
2022年 | 3855篇 |
2021年 | 6772篇 |
2020年 | 10644篇 |
2019年 | 15019篇 |
2018年 | 14217篇 |
2017年 | 15732篇 |
2016年 | 14900篇 |
2015年 | 14777篇 |
2014年 | 17733篇 |
2013年 | 18528篇 |
2012年 | 16866篇 |
2011年 | 17230篇 |
2010年 | 14133篇 |
2009年 | 10336篇 |
2008年 | 10696篇 |
2007年 | 9128篇 |
2006年 | 8258篇 |
2005年 | 7523篇 |
2004年 | 6772篇 |
2003年 | 6181篇 |
2002年 | 5378篇 |
2001年 | 4505篇 |
2000年 | 2933篇 |
1999年 | 1634篇 |
1998年 | 1366篇 |
1997年 | 1263篇 |
1996年 | 1075篇 |
1995年 | 976篇 |
1994年 | 931篇 |
1993年 | 735篇 |
1992年 | 685篇 |
1991年 | 592篇 |
1990年 | 502篇 |
1989年 | 502篇 |
1988年 | 437篇 |
1987年 | 396篇 |
1986年 | 314篇 |
1985年 | 397篇 |
1984年 | 316篇 |
1983年 | 187篇 |
1982年 | 220篇 |
1981年 | 184篇 |
1980年 | 160篇 |
1979年 | 125篇 |
1978年 | 88篇 |
1977年 | 60篇 |
1976年 | 75篇 |
1974年 | 46篇 |
排序方式: 共有10000条查询结果,搜索用时 234 毫秒
51.
52.
53.
《European journal of medical genetics》2020,63(9):103981
Congenital diarrhea and enteropathies (CODEs) are a group of monogenic disorders that often present with severe diarrhea in the first weeks of life. Enteric anendocrinosis (EA), an extremely rare cause of CODE, is characterized by a marked reduction of intestinal enteroendocrine cells (EC). EA is associated with recessively inherited variants in Neurogenin-3 (NEUROG3) gene. Here we investigate a case of a male infant who presented with mysterious severe malabsorptive diarrhea since birth. Thorough clinical assessments and laboratory tests were successful to exclude the majority of differential diagnosis categories. However, the patient's diagnosis was not established until the genetic test using whole-exome sequencing (WES) was performed. We identified a novel homozygous missense disease-causing variant (DCV) in NEUROG3 (c.413C>G, p.Thr138Arg). Moreover, molecular dynamic simulation analysis showed that (p.Thr138Arg) led to a global change of the NEUROG3 orientation affecting its DNA binding capacity. To the best of our knowledge, this is the first time to apply WES to reach a differential diagnosis of patients with CODEs. Our study not only expands our knowledge about NEUROG3 variants and their clinical consequences but also proves that WES is a very effective tool for the diagnosis of CODEs. This might be of value in early diagnosis of diseases and prenatal CODEs detection. 相似文献
54.
Cost‐Effectiveness and Cost‐Utility Analysis of Spinal Cord Stimulation in Patients With Failed Back Surgery Syndrome: Results From the PRECISE Study 下载免费PDF全文
Furio Zucco MD Roberta Ciampichini MSc Angelo Lavano MD Amedeo Costantini MD Marisa De Rose MD Paolo Poli MD Gianpaolo Fortini MD Laura Demartini MD Enrico De Simone MD Valentino Menardo MD Piero Cisotto MD Mario Meglio MD Luciana Scalone PhD Lorenzo G. Mantovani DSc 《Neuromodulation》2015,18(4):266-276
55.
56.
In this article, we draw on recent scholarly work in the poststructuralist analysis of policy to consider how policy itself functions as a key site in the constitution of alcohol ‘problems’, and the political implications of these problematisations. We do this by examining Australian alcohol policy as it relates to young adults (18–24 years old). Our critical analysis focuses on three national alcohol policies (1990, 2001 and 2006) and two Victorian state alcohol policies (2008 and 2013), which together span a 25-year period. We argue that Australian alcohol policies have conspicuously ignored young adult men, despite their ongoing over-representation in the statistical ‘evidence base’ on alcohol-related harm, while increasingly problematising alcohol consumption amongst other population subgroups. We also identify the development of a new problem representation in Australian alcohol policy, that of ‘intoxication’ as the leading cause of alcohol-related harm and rising hospital admissions, and argue that changes in the classification and diagnosis of intoxication may have contributed to its prioritisation and problematisation in alcohol policy at the expense of other forms of harm. Finally, we draw attention to how preliminary and inconclusive research on the purported association between binge drinking and brain development in those under 25 years old has been mobilised prematurely to support calls to increase the legal purchasing age from 18 to 21 years. Our critical analysis of the treatment of these three issues – gender, intoxication, and brain development – is intended to highlight the ways in which policy functions as a key site in the constitution of alcohol ‘problems’. 相似文献
57.
Sophocarpine attenuates toll‐like receptor 4 in steatotic hepatocytes to suppress pro‐inflammatory cytokines synthesis 下载免费PDF全文
58.
59.
60.
Simeprevir added to peginterferon and ribavirin lessens time with fatigue,depressive symptoms and functional limitations in patients with chronic hepatitis C compared with peginterferon and ribavirin: results from 1161 patients in the QUEST‐1, QUEST‐2 and PROMISE studies 下载免费PDF全文
J. Scott L. Gilles M. Fu E. Brohan C. Panter R. Arbuckle W. Jessner M. Beumont 《Journal of viral hepatitis》2015,22(8):639-650
The value of adding simeprevir (SMV) vs placebo (PBO) to peginterferon and ribavirin (PR) for treatment of chronic hepatitis C virus infection was examined using patient‐reported outcomes (PROs); further, concordance of PROs with virology endpoints and adverse events (AEs) was explored. Patients (n = 768 SMV/PR, n = 393 PBO/PR) rated fatigue (FSS), depressive symptoms (CES‐D) and functional impairment (WPAI: Hepatitis C Productivity, Daily Activity and Absenteeism) at baseline and throughout treatment in three randomised, double‐blind trials comparing the addition of SMV or PBO during initial 12 weeks of PR. PR was administered for 48 weeks (PBO group) and 24/48 weeks (SMV group) using a response‐guided therapy (RGT) approach. Mean PRO scores (except Absenteeism) worsened from baseline to Week 4 to the same extent in both groups but reverted after Week 24 for SMV/PR and only after Week 48 for PBO/PR. Accordingly, there was a significantly lower area under the curve (baseline–Week 60, AUC60) and fewer weeks with clinically important worsening of scores in the SMV/PR group at any time point. Incidences of patients with fatigue and anaemia AEs were similar in both groups, but FSS scores showed that clinically important increases in fatigue lasted a mean of 6.9 weeks longer with PBO/PR (P < 0.001). PRO score subgroup analysis indicated better outcomes for patients who met the criteria for RGT or achieved sustained virological response 12 weeks post‐treatment (SVR12); differences in mean PRO scores associated with fibrosis level were only observed with PBO/PR. Greater efficacy of SMV/PR enabled reduced treatment duration and reduced time with PR‐related AEs without adding to AE severity. 相似文献